|Systematic (IUPAC) name|
|Pregnancy cat.||C (US)|
|Legal status||OTC (US)|
|ATC code||N01 R02|
|Mol. mass||289.413 g/mol|
|(what is this?)|
Dyclonine is an oral anaesthetic that is the active ingredient of Sucrets, an over the counter throat lozenge. It is also found in some varieties of the Cepacol sore throat spray. It is a local anesthetic, used topically as the hydrochloride salt.
In 1966 the Federal Trade Commission ordered Merck and Company to discontinue the false claims of germ-killing and pain-relieving properties for its Sucrets and Children's Sucrets throat lozenges. In 1977, it was acquired by Beecham, later merging with SmithKline Beckman in 1989 to form SmithKline Beecham. By 1994 the brand switched from a metal container to a plastic container. SmithKline Beecham, after announcing a merger with GlaxoWellcome to form GlaxoSmithKline, sold the brand in 2000 to Insight Pharmaceuticals. In 2011, Sucrets reintroduced their product back into the familiar tin due to popular demand and nostalgia.
- Janice Jorgensen (1994). "Sucrets". Encyclopedia of Consumer Brands: Personal products. St. James Press. Retrieved 2011-09-24.
- Gargiulo, A. V.; Burns, G. M.; Huck, C. P. (1992). "Dyclonine hydrochloride--a topical agent for managing pain". Illinois dental journal 61 (4): 303–304. PMID 1286862.
- "The Sucrets tin joins the age of plastics". USA Today. July 19, 1994. Retrieved 2011-09-24. "Invented in Baltimore by Sharp & Dohme pharmaceutical in 1932, Sucrets have always been sold in the trademark metal box except for one 4 1/2-month period during the late 1960s when a tin shortage led to cardboard packaging, says [Frank Dzvonik]."
- "F.T.C. Bids Merck Halt Claims That Lozenges Will Kill Germs". Associated Press in the New York Times. April 19, 1966. Retrieved 2011-09-24.
|This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|